FT. LAUDERDALE, Fla., July 7 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials announced today that its Board of Directors has retained Emerging Growth Equities, Ltd. (EGE) as its strategic financial advisor to assist in evaluating strategic alternatives with a focus on acquisitions that may be available to the Company.
"We believe that the scope of our product offerings and broad team of experienced eClinical experts provide us with an excellent opportunity to continue executing on our strategy of increasing our presence in the eClinical market. In particular, we are focused on increasing our penetration of a broader spectrum of clients by expanding the scope of integrated eClinical solutions we can offer our clients. We feel strongly that the time is right to engage EGE to assist the company in enhancing shareholder value and advancing the company's overall growth strategy," said Cornelis F. Wit, OmniComm's President and CEO. "EGE has been a valuable advisor to us in the past on both capital transactions and in our recent acquisition of eResearch Technology's EDC business. We believe they bring a wealth of experience and expertise in the healthcare IT sector and are an excellent strategic partner for us in the process of evaluating opportunities for strategic growth. Given the recent move towards consolidation in our industry and our investment in infrastructure over the past few years we believe that there may be value to our customers and our shareholders in exploring transactions that will allow us to grow our product line as well as the depth and breadth of our customer pipeline."
Emerging Growth Equities, Ltd., President and CEO, Greg Berlacher stated, "We are very excited about the opportunity to work with one of the fastest growing and innovative companies in the EDC space today. We have worked with this management team in the past and believe they have significant opportunities to gain market share in the near future."
About OmniComm Systems, Inc.
OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Chicago, Germany, Tula, Russia, California, New York, New Jersey, North Carolina, Tennessee, Massachusetts and Georgia.
About Emerging Growth Equities, Ltd.
Emerging Growth Equities, Ltd. ("EGE") was founded in September of 1999 as a specialty investment banking and brokerage firm focused on working with early and middle stage technology companies in high-growth industries. As a full-service investment banking and brokerage firm, EGE provides a range of financial services including public and private equity offerings, institutional research, sales and trading, and strategic and financial advisory services.
Safe Harbor Disclaimer
Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
'/>"/>
| SOURCE OmniComm Systems, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. OmniComm Systems, Inc. Raises $5.1 Million in Convertible Debt Financing
2. Medical Data Systems, Inc. (MDS) Announces Operations Expansion and Opening of its Primary Collections Operations Office
3. Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort
4. Sentry Data Systems, Inc. Announces: Sentinel RCM(TM) - Now with Mobile Manager(TM) Included!
5. Misonix Subsidiary, Sonora Medical Systems, Achieves ISO 17025 Accreditation
6. AdCare Health Systems, Inc. Turns Profitable; Reports 2009 First Quarter Earnings Results
7. MMR Information Systems, Inc. Receives Licensing Proposal Involving the Companys Anti-CD20 Antibodies
8. Syntex Management Systems, Inc. to Discuss Enterprise Risk Management at the North American Petroleum Accounting Conference
9. Dynasplint Systems, Inc. Launches Two New Web Sites Plus Social Media Tools
10. MMR Information Systems, Inc. Announces Ticker Symbol Change
11. MMR Information Systems, Inc. Announces 250,000 Membership Milestone and Granting of International Patents
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |